Monsanto´s genetically engineered maize produces six different insecticides
Monday, 3 June 2013
Munich/Brussels
On 10 June, the EU Commission and representatives from EU Member States are set to discuss and probably vote on the market authorisation of the genetically engineered maize SmartStax for use in food and feed. SmartStax is a joint Monsanto and Dow AgroSciences product that produces six insecticidal proteins and is tolerant to two herbicides. Although dossiers from the industry showed substantial flaws its market authorisation was viewed favourably by the European Food Safety Authority (EFSA) in 2010. For example, combinatorial effects between the insecticidal toxins and the residues from spraying were never investigated. So far, SmartStax is not authorised for sale on the EU market. In December 2012, Testbiotech raised the alarm warning that the maize might have already entered the market illegally. Instead of stopping imports, the Commission is now pressing ahead by trying to force a decision through allowing SmartStax for use in food and feed.
European Food Safety Authority mishandled a major revolving doors case with biotechnology company Syngenta
Wednesday, 29 May 2013
Brussels/Munich
In a May 23d ruling, the EU Ombudsman stated that EFSA (European Food Safety Authority ) failed to take adequate measures to prevent conflict of interests arising from a major 'revolving doors' case in 2008.
German civil society groups urge parliament and the government to fight the influence of industry
Thursday, 16 May 2013
Munich
Today a broad coalition of civil society groups in Germany are starting a petition calling on the German Parliament to strengthen the position of independent risk research especially in the field of biotechnology. “Despite criticism raised by many sides, the German government has not yet taken any action. Our petition gives the German parliament an opportunity to send a clear signal”, says Ruth Tippe for the Gene-Ethic Foundation which officially filed the petition.
14000 signatures against patents held by US company Intrexon
Friday, 3 May 2013
Munich
After more than 14.000 people signed a petition, several organisations have filed an opposition against the European patent EP1572862 held by the US company, Intrexon. The patent was granted by the European Patent Office (EPO) in 2012 and claims many animal species including chimpanzees. According to the patent, the company wants to manipulate the animals with artificial DNA synthesized in partial analogy to the genome of insects. Intrexon is working in the field of “synthetic biology” and aims to produce animals with changed gene regulation to sell to the pharmaceutical industry.